Literature DB >> 2567765

Infection following caesarean section.

T Parrott1, A J Evans, A Lowes, K J Dennis.   

Abstract

In a prospective clinical study of post-operative infection in 124 patients undergoing Caesarean section, 39 (31.5%) patients developed a total of 45 infections. There was no significant difference in infection rates between elective and emergency procedures. Five patients (4%) developed endometritis, wound infection was found in 14 (11.3%) and 18 patients (14.5%) developed a post-operative urinary tract infection. Pre-operative C-reactive protein levels and intraoperative swabs of the uterine cavity were not helpful in the early detection of endometritis. The risk factors predisposing to post-caesarean infection were obesity and low socioeconomic status.

Entities:  

Mesh:

Year:  1989        PMID: 2567765     DOI: 10.1016/0195-6701(89)90054-6

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  4 in total

1.  Acute care visits and rehospitalization in women and infants after cesarean birth.

Authors:  D Donahue; D Brooten; M Roncoli; L Arnold; H Knapp; L Borucki; A Cohen
Journal:  J Perinatol       Date:  1994 Jan-Feb       Impact factor: 2.521

2.  A randomized trial of early hospital discharge and home follow-up of women having cesarean birth.

Authors:  D Brooten; M Roncoli; S Finkler; L Arnold; A Cohen; M Mennuti
Journal:  Obstet Gynecol       Date:  1994-11       Impact factor: 7.661

Review 3.  Growth factors, silver dressings and negative pressure wound therapy in the management of hard-to-heal postoperative wounds in obstetrics and gynecology: a review.

Authors:  Paweł Jan Stanirowski; Anna Wnuk; Krzysztof Cendrowski; Włodzimierz Sawicki
Journal:  Arch Gynecol Obstet       Date:  2015-04-12       Impact factor: 2.344

4.  Postpartum urinary tract infection by mode of delivery: a Danish nationwide cohort study.

Authors:  Tina Djernis Gundersen; Lone Krebs; Ellen Christine Leth Loekkegaard; Steen Christian Rasmussen; Julie Glavind; Tine Dalsgaard Clausen
Journal:  BMJ Open       Date:  2018-03-14       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.